Skip to content

Comparison of Alfentanil and Sufentanil for General Anesthesia in Complex Impacted Tooth Extraction

Use of Alfentanil for Analgesia and Sedation in Dental Procedures

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114845
Enrollment
Unknown
Registered
2025-12-18
Start date
2025-04-04
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impacted tooth

Interventions

Alfentanil group:none

Sponsors

School and Hospital of Stomatology, Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Age ranged from 18 to 65 years; (2) American Society of Anesthesiologists (ASA) physical status classification of Grade I-II ; (3) Expected operation duration between 30 minutes and 2 hours; (4) Anesthesia protocol was total intravenous anesthesia (TIVA) or combined intravenous-inhalation anesthesia, with alfentanil or sufentanil as the main intraoperative analgesic.

Exclusion criteria

Exclusion criteria: (1) Severe hepatic or renal insufficiency (Child-Pugh Class C or estimated glomerular filtration rate [eGFR] 200ml or requirement for blood transfusion; (4) Allergy to any drugs involved in this study; (5) Intraoperative use of other adjuvant analgesics (e.g., ketamine, dexmedetomidine); (6) Severe deficiency of medical record data (e.g., lack of continuous intraoperative vital sign records or key medication records); (7) Known difficult airway or significant changes in intraoperative anesthesia protocol; (8)Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
hemodynamic stability;

Secondary

MeasureTime frame
Baseline data: demographic information (age, gender, weight, height, body mass index [BMI]), ASA classification, comorbidities (e.g., hypertension, diabetes),and preoperative baseline vital signs (the average of three consecutive measurements of MAP and HR in a calm state after entering the operating room);Perioperative data:type and duration of surgery,duration of anesthesia,types and doses of all medications administered ;Awakening time;Time to achieve a Steward score 6;PACU length of stay;Incidence of intraoperative hypertensionand intraoperative hypotension;Incidence of adverse events(e.g.,respiratory depression,nausea and vomiting,dizziness)in the PACU and the dosage of rescueanalgesics administered;

Countries

China

Contacts

Public ContactHe Zexiu

School and Hospital of Stomatology, Hebei Medical University

hzx8623@outlook.com+86 188 4241 8623

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026